These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21001625)

  • 1. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).
    CARLETON AB; PETERS RA
    J Clin Invest; 1946 Jul; 25(4):497-527. PubMed ID: 21001625
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of acute gold and arsenic poisoning; use of BAL (2,3-dimercaptopropanol, British anti-lewisite).
    COHEN A; GOLDMAN J; DUBBS AW
    J Am Med Assoc; 1947 Mar; 133(11):749-52. PubMed ID: 20283984
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment by 2,3-dimercaptopropanol (BAL) of the systemic toxic effects of skin contamination with lewisite and phenyldichlorarsine.
    HARRISON HE; DURLACHER SH
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):81-4. PubMed ID: 20275117
    [No Abstract]   [Full Text] [Related]  

  • 5. Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
    HARRISON HE; ORDWAY NK
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):76-80. PubMed ID: 20275116
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL.
    HUGHES WF
    J Clin Invest; 1946 Jul; 25(4):541-8. PubMed ID: 21001628
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
    RIKER WF; ROSENFELD G
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115
    [No Abstract]   [Full Text] [Related]  

  • 10. BAL (British anti-lewisite) in the treatment of arsenic and mercury poisoning.
    J Am Med Assoc; 1946 Jul; 131():824. PubMed ID: 20987433
    [No Abstract]   [Full Text] [Related]  

  • 11. Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL).
    Snider TH; Wientjes MG; Joiner RL; Fisher GL
    Fundam Appl Toxicol; 1990 Feb; 14(2):262-72. PubMed ID: 2318351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. British anti-lewisite; dithiol compounds as antidotes for arsenic.
    STOCKEN LA; THOMPSON RH
    Biochem J; 1946 Jul; 40(4):535-48. PubMed ID: 20273639
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical injury in arsenical intoxication and the British Anti-Lewisite].
    PETERS RA
    Rev Med Liege; 1948 Dec; 3(23):687-98. PubMed ID: 18100780
    [No Abstract]   [Full Text] [Related]  

  • 14. British anti-Lewisite. III. Developments and applications.
    PETERS RA
    J R Inst Public Health; 1952 Jun; 15(6):151-67. PubMed ID: 14939268
    [No Abstract]   [Full Text] [Related]  

  • 15. The systemic treatment of arsenic poisoning with BAL (2,3-dimercaptopropanol).
    EAGLE H
    J Vener Dis Inf; 1946 May; 27():114-21. PubMed ID: 21028660
    [No Abstract]   [Full Text] [Related]  

  • 16. British anti-Lewisite. II. Dithiols as antidotes.
    PETERS RA
    J R Inst Public Health; 1952 May; 15(5):122-39. PubMed ID: 14918251
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of BAL (2,3-dimercaptopropanol) in the treatment of agranulocytosis following intensive arsenotherapy for syphilis.
    HOLLEY HL
    Ann Intern Med; 1947 Aug; 27(2):231-8. PubMed ID: 20257488
    [No Abstract]   [Full Text] [Related]  

  • 18. Modeling the chelation of As(III) in lewisite by dithiols using density functional theory and solvent-assisted proton exchange.
    Harper LK; Bayse CA
    J Inorg Biochem; 2015 Dec; 153():60-67. PubMed ID: 26479948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical uses of 2,3-dimercaptopropanol (BAL); studies on the toxicity of BAL on percutaneous and parenteral administration.
    SULZBERGER MB; BAER RL; KANOF A
    J Clin Invest; 1946 Jul; 25(4):474-9. PubMed ID: 21001622
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical uses of 2,3-dimercaptopropanol (BAL); skin sensitization to BAL.
    SULZBERGER MB; BAER RL; KANOF A
    J Clin Invest; 1946 Jul; 25(4):488-96. PubMed ID: 21001624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.